background

Neratinib Impurity 2

Neratinib Impurity 2

Watermark

Neratinib Impurity 2

CAT No:	CL-NTB-05
CAS No:	848139-78-6
Mol.F:	C24H20ClN5O2
Mol.Wt.:	445.9
Chemical Name:	6-Amino-4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxyquinoline-3-carbonitrile
Inventory Status:	Custom synthesis

This impurity is related to Neratinib Impurity 2 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

Neratinib Impurity 2 is used as a reference standard in analytical research. It ensures consistency of formulations.

Chemical Name:6-Amino-4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxyquinoline-3-carbonitrile
Country of Origin: India
Product Category: Impurity Reference Standard
API NAME: Neratinib
Molecular Formula: C24H20ClN5O2
Molecular Weight: 445.9
Storage: Store in a cool, dry place.

Where We Can Provide

Relatd Products

N-Nitroso Neratinib Impurity 1

Watermark

Cat. No: CL-NTB-NO-01

CAS No: NA

Mol. F: C29H26ClN7O4

Mol. Wt: 572.1

Inv. Status: NA

N-Nitroso Neratinib Impurity 2

Watermark

Cat. No: CL-NTB-NO-02

CAS No: NA

Mol. F: C13H12ClN3O2

Mol. Wt: 277.7

Inv. Status: Custom Synthesis

Neratinib

Watermark

Cat. No: CL-NTB-01

CAS No: 698387-09-6

Mol. F: C30H29ClN6O3

Mol. Wt: 557.1

Inv. Status: Custom Synthesis

N-Nitroso Neratinib Impurity 3

Watermark

Cat. No: CL-NTB-NO-03

CAS No: NA

Mol. F: C30H28ClN7O4

Mol. Wt: 586.05

Inv. Status: Custom Synthesis

N-Nitroso Neratinib D6

Watermark

Cat. No: CL-NTB-NO-04

CAS No: NA

Mol. F: C30H22D6CLN7O4

Mol. Wt: 592.1

Inv. Status: Custom Synthesis

N-Nitroso Neratinib Maleate

Watermark

Cat. No: CL-NTB-NO-05

CAS No: NA

Mol. F: C34H32CLN7O8

Mol. Wt: 702.1

Inv. Status: Custom Synthesis

N-Nitroso Neratinib Impurity 4

Watermark

Cat. No: CL-NTB-NO-06

CAS No: NA

Mol. F: C25H19CLN6O4

Mol. Wt: 502.9

Inv. Status: Custom Synthesis

N-Nitroso Neratinib Impurity 5

Watermark

Cat. No: CL-NTB-NO-07

CAS No: NA

Mol. F: C24H19CLN6O3

Mol. Wt: 474.9

Inv. Status: Custom Synthesis

N-Nitroso Neratinib Impurity 6

Watermark

Cat. No: CL-NTB-NO-08

CAS No: NA

Mol. F: C30H28CLN7O5

Mol. Wt: 602

Inv. Status: Custom Synthesis

N-Nitroso Neratinib Impurity 7

Watermark

Cat. No: CL-NTB-NO-09

CAS No: NA

Mol. F: C30H28CLN7O5

Mol. Wt: 602

Inv. Status: Custom Synthesis

N-Nitroso Neratinib Impurity 8

Watermark

Cat. No: CL-NTB-NO-10

CAS No: NA

Mol. F: C30H28CLN7O6

Mol. Wt: 618

Inv. Status: Custom Synthesis

N-Nitroso Neratinib Impurity 9

Watermark

Cat. No: CL-NTB-NO-11

CAS No: NA

Mol. F: C29H26ClN7O4

Mol. Wt: 572.01

Inv. Status: Custom Synthesis

Neratinib D6

Watermark

Cat. No: CL-NTB-02

CAS No: 1259519-18-0

Mol. F: C30H23D6ClN6O3

Mol. Wt: 563.1

Inv. Status: Custom Synthesis

N-Desmethyl Neratinib

Watermark

Cat. No: CL-NTB-03

CAS No: 915788-27-1

Mol. F: C29H27ClN6O3

Mol. Wt: 543

Inv. Status: Custom Synthesis

Neratinib Dimethylamine N-Oxide (M7)

Watermark

Cat. No: CL-NTB-04

CAS No: 1376615-55-2

Mol. F: C30H29ClN6O4

Mol. Wt: 573.1

Inv. Status: Custom Synthesis

Neratinib Pyridine N-Oxide

Watermark

Cat. No: CL-NTB-06

CAS No: 1376619-94-1

Mol. F: C30H29ClN6O4

Mol. Wt: 573.1

Inv. Status: Custom Synthesis

Neratinib Bis-N-Oxide (M11)

Watermark

Cat. No: CL-NTB-07

CAS No: NA

Mol. F: C30H29ClN6O5

Mol. Wt: 589

Inv. Status: Custom Synthesis

Neratinib Impurity 1

Watermark

Cat. No: CL-NTB-08

CAS No: 1144516-20-0

Mol. F: C25H20ClN5O3

Mol. Wt: 473.9

Inv. Status: Custom Synthesis

Neratinib Quinoline N-Oxide

Watermark

Cat. No: CL-NTB-09

CAS No: 1348481-03-7

Mol. F: C30H29ClN6O4

Mol. Wt: 573.1

Inv. Status: Custom Synthesis

Neratinib Impurity 3

Watermark

Cat. No: CL-NTB-10

CAS No: 1144516-15-3

Mol. F: C28H24ClN5O4

Mol. Wt: 530

Inv. Status: Custom Synthesis

Neratinib Impurity 4

Watermark

Cat. No: CL-NTB-11

CAS No: 1144516-19-7

Mol. F: C28H25ClN6O4

Mol. Wt: 545

Inv. Status: Custom Synthesis

Document